Effects of Inhalation of STIM-Orai Antagonist SKF 96365 on Ovalbumin-Induced Airway Remodeling in Guinea Pigs
- 20 March 2021
- book chapter
- Published by Springer Nature
- Vol. 1335, 87-101
Abstract
Airway remodeling (AR) consists of wall thickening and hyperreactivity. STIM (stromal interaction molecule) and Orai protein pathways mediate extracellular Ca2+ signals involved in AR. This study aims to define the effects on AR of the STIM-Orai antagonist SKF 96365 given by inhalation in three increasing doses in ovalbumin-induced AR. In the control group, the antiasthmatic budesonide and salbutamol were given in the same model. The airway structure was evaluated by histological and immunohistochemistry and reactivity by specific airway resistance, contraction strength of isolated airway smooth muscles, and mucociliary clearance expressed by ciliary beating frequency. The immuno-biochemical markers of chronic inflammation were evaluated by BioPlex and ELISA assays. The AR was mediated by inflammatory cytokines and growth factors. The findings show significant anti-remodeling effects of SKF 96365, which were associated with a decrease in airway hyperreactivity. The anti-remodeling effect of SKF 96365 was mediated via the suppression of IL-4, IL-5, and IL-13 synthesis, and IL-12–INF-γ–TGF-β pathway. The budesonide-related AR suppression had to do with a decrease in proinflammatory cytokines and an increase in the anti-inflammatory IL-10, with negligible influence on growth factors synthesis and mucous glands activity.Keywords
This publication has 58 references indexed in Scilit:
- Bronchoconstriction Induces TGF-β Release and Airway Remodelling in Guinea Pig Lung SlicesPLOS ONE, 2013
- Airway smooth muscle STIM1 and Orai1 are upregulated in asthmatic mice and mediate PDGF-activated SOCE, CRAC currents, proliferation, and migrationPflügers Archiv - European Journal of Physiology, 2012
- PPARγas a Potential Target to Treat Airway Mucus Hypersecretion in Chronic Airway Inflammatory DiseasesPPAR Research, 2012
- The transient receptor potential channel antagonist SKF96365 is a potent blocker of low‐voltage‐activated T‐type calcium channelsBritish Journal of Pharmacology, 2010
- Molecular Basis of Calcium Signaling in Lymphocytes: STIM and ORAIAnnual Review of Immunology, 2010
- IL-12-STAT4-IFN-γ axis is a key downstream pathway in the development of IL-13-mediated asthma phenotypes in a Th2 type asthma modelExperimental & Molecular Medicine, 2010
- Ion channel regulation of intracellular calcium and airway smooth muscle functionPulmonary Pharmacology & Therapeutics, 2009
- The cytokine network in asthma and chronic obstructive pulmonary diseaseJournal of Clinical Investigation, 2008
- New drugs targeting Th2 lymphocytes in asthmaJournal of Occupational Medicine and Toxicology, 2008
- Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release–activated calcium channelsNature Immunology, 2007